M&A Deal Summary

Mallinckrodt Acquires Liebel-Flarsheim

On January 31, 1996, Mallinckrodt acquired medical products company Liebel-Flarsheim for 75M USD

Acquisition Highlights
  • This is Mallinckrodt’s 1st transaction in the Medical Products sector.
  • This is Mallinckrodt’s 8th largest (disclosed) transaction.
  • This is Mallinckrodt’s 1st transaction in the United States.
  • This is Mallinckrodt’s 1st transaction in Ohio.

M&A Deal Summary
Date 1996-01-31
Target Liebel-Flarsheim
Sector Medical Products
Buyer(s) Mallinckrodt
Deal Type Add-on Acquisition
Deal Value 75M USD

Target

Liebel-Flarsheim

Cincinnati, Ohio, United States
Liebel-Flarsheim Co.,LLC manufactures x-ray urological tables and components for numerous OEM customers and markets digital spot and R/F interventional tables under its own label.

Search 193,381 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Mallinckrodt

Dublin, United Kingdom

website

Category Company
Founded 1867
Sector Life Science
Employees2,673
Revenue 2.2B USD (2021)
DESCRIPTION

Mallinckrodt is a specialty pharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. Mallinckrodt was founded in 1867 and is based in Dublin, Ireland.

DEAL STATS #
Overall 1 of 12
Sector (Medical Products) 1 of 3
Type (Add-on Acquisition) 1 of 10
State (Ohio) 1 of 1
Country (United States) 1 of 11
Year (1996) 1 of 1
Size (of disclosed) 8 of 9
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
1999-12-17 HemoCue AB

Angelholm, Sweden

For more than 10 years, HemoCue had been a recognized global leader in professional diagnostics point-of-care testing. The product strategies behind HemoCue's success where based on a clear focus on important diagnostic tests of the highest quality, which was fast and easy to perform by anyone.

Sell -
Mergr

Product

Company

Legal